<DOC>
	<DOCNO>NCT00334581</DOCNO>
	<brief_summary>Primary objective : - To determine irbesartan 300mg well 150mg protect kidney hypertensive patient diabetes microalbuminuria . Secondary objective : - To determine well irbesartan 300mg tolerate versus 150mg - To determine percentage patient reach blood pressure target 130/80 mmHg</brief_summary>
	<brief_title>Irbesartan Chinese Hypertensive Diabetics With Microalbuminuria</brief_title>
	<detailed_description />
	<mesh_term>Irbesartan</mesh_term>
	<criteria>Hypertensive patient , treat untreated , type 2 diabetes urinary albumin excretion rate 20200ug/min . Blood pressure &lt; 180/110mmHg baseline Normal serum creatinine Type 1 diabetes Use angiotensin convert enzyme inhibitor angiotensin receptor blocker 5 week recruitment Pregnant lactate woman Severe hypertension Overt nephropathy Allergy study drug The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>